‘This looks like the real deal’: are we inching closer to a treatment for Alzheimer’s? | Health
At the end of November, thousands of researchers from around the world will descend on San Francisco for the annual Clinical Trials on Alzheimer’s Disease meeting. The conference is a mainstay of the dementia research calendar, the place where the latest progress – and all too often, setbacks – in the quest for Alzheimer’s treatments are made public for the first time. This year’s meeting is poised to be a landmark event. After more than a century of research into…